Abbott Laboratories

Type: Company
Name: Abbott Laboratories
Nationality: United States
First reported 3 hours ago - Updated 1 hour ago - 3 reports

Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien

LONDONInvestor-Edge has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), ResMed Inc. (NYSE: RMD), and Covidien PLC (NYSE: COV). Free research on these five companies ... [Published Bio-Medicine - 1 hour ago]
First reported 9 hours ago - Updated 4 hours ago - 1 reports

Abbott Laboratories : Director/PDMR Shareholding

Notification to RNSCompany: Abbott LaboratoriesTIDM: ABTHeadline: Abbott Laboratories Files Form 4 Abbott Laboratories (the "Company30 October 2014Abbott Laboratories Files Form 4The Company informs its shareholders that on 30 October 2014, in accordance ... [Published Investegate - 9 hours ago]
First reported Oct 30 2014 - Updated 4 hours ago - 1 reports

Potential Abbott Laboratories (ABT) Trade Targets 2.77% Return

Abbott Laboratories (ABT) is a good candidate for a covered call at the $43.00 level. The Dec. '14 call at that price should fetch a credit of about $0.90, which means the entire position has a net debit of about $41.84. This trade has 0.09% downside ... [Published MarketIntelligenceCenter.com - Oct 30 2014]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Insider Selling: Abbott Laboratories CEO Sells 440,800 Shares of Stock (ABT)

Abbott Laboratories (NYSE:ABT) CEO Miles D. White sold 440,800 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $42.52, for a total transaction of $18,742,816.00. ... [Published American Banking News - 13 hours ago]
First reported Oct 29 2014 - Updated 21 hours ago - 4 reports

Abbott to acquire VC-backed Topera for $250 mln

Abbott has agreed to buy Topera , which is backed by New Enterprise Associates , for $250 million. Based in Menlo Park, Calif., Topera is a medical device firm focused on developing technologies that improve the diagnosis and treatment of atrial ... [Published PE Hub Blog - 21 hours ago]
First reported Oct 30 2014 - Updated Oct 30 2014 - 1 reports

VytronUS raises $31.6M as its CEO jumps to run new Abbott Labs unit

Medical device startup VytronUS gained $31.6 million and lost a CEO this week.The Sunnyvale company that develops technology for people with irregular heartbeats said CEO Michael Pederson will be leaving for Abbott later this quarter to lead that company's ... [Published San Jose Business Journal - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 30 2014 - 3 reports

Abbott Labs to buy Menlo Park's Topera for $250M

Abbott Laboratories has agreed to buy Topera Inc., a Menlo Park-based medical device company for $250 million up front, with further payments based on certain performance factors.Abbott (NYSE: ABT) said it sees the Topera acquisition as a way to get into ... [Published San Jose Business Journal - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

Abbott Laboratories’s “Neutral” Rating Reaffirmed at Zacks (ABT)

Zacks reiterated their neutral rating on shares of Abbott Laboratories (NYSE:ABT) in a research report released on Monday morning. Zacks currently has a $45.00 price objective on the stock. Zacks’ analyst wrote, “Abbott Laboratories reported third-quarter ... [Published Mideast Time - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 3 reports

Abbott Labs Teams Up With NEA to Enter Electrophysiology Market

(c) 2014 Dow Jones & Company, Inc.Pharmaceutical giant Abbott Laboratories is moving into a treatment area where it has traditionally had little presence, the treatment of atrial fibrillation and other heart arrhythmias through the ablation of tiss ... [Published Dow Jones Financial Information Services - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 1 reports

ABBOTT LABORATORIES : ' Trademark Application for "INDEFLATOR" Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "INDEFLATOR" by Anamaria E. Cashman , representing Abbott ... [Published 4 Traders - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 2 reports

The Zacks Analyst Blog Highlights:AbbVie, Mylan, Abbott Laboratories, Actavis and Mallinckrodt

Today, Zacks is promoting its ''Buy'' stock recommendations. . Here are highlights from Tuesday's Analyst Blog:3 Generics Stocks to Buy NowThe pharma sector experienced one of its most significant turning points 30 years ago when the Hatch-Waxman Act ... [Published Industrial Info Financials - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 1 reports

Abbott Laboratories (ABT) Showing Support Near $41.76

Tuesday’s trading in Abbott Laboratories (ABT) gives options traders an opportunity for a 6.67% return. By selling the Dec. '14 $43.00 call and buying the Jan. '16 call at the $35.00 level for a net debit of $7.50, traders will book a profit as long as ... [Published MarketIntelligenceCenter.com - Oct 29 2014]

Quotes

"We still don't believe that minor differences in pill count or shorter duration of therapy in certain patients will significantly change the competitive dynamics in this marketplace" Chief Executive Richard Gonzalez said
"We see today's results as reinforcing our view that AbbVie shares remain well-positioned heading into 2015" said JPMorgan analyst Chris Schott...
Scientists ... could help doctors diagnose this baffling condition and shed ... syndrome are often misdiagnosed or labeled as hypochondriacs. ... "we found that [chronic fatigue syndrome] patients, brains diverge ..."
"We're going to continue to look for those opportunities that strategically fit and give us a strong financial return" he said, "and we'll deploy our capital accordingly."

More Content

All (1237) | News (921) | Reports (1) | Blogs (282) | Audio/Video (1) | Fact Sheets (10) | Press Releases (21)
sort by: Date | Relevance
Mylan (MYL) Earnings Report: Q3 2014 Conference... [Published Daily Freeman - 9 mins ago]
AbbVie Boosts Earnings Guidance, Posts Higher S... [Published 4 Traders - 16 mins ago]
UPDATE 2-AbbVie says strong results lessen need... [Published CNBC - 1 hour ago]
Report: Stem Cell Technologies Market Growing [Published Bio-Medicine - 1 hour ago]
Health Care Equipment Stocks Technical Insight ... [Published Bio-Medicine - 1 hour ago]
Companion Diagnostics Market: Global Industry A... [Published Digital Journal - 1 hour ago]
After strong Q3, no $55 billion deals in AbbVie... [Published FiercePharma - 2 hours ago]
Baby Nutrition Insights 2014 - Issue 18 - New M... [Published Digital Journal - 2 hours ago]
China lifts import ban on Fonterra whey product... [Published Food Processing Technology - 3 hours ago]
Health Care Equipment Stocks Technical Insight ... [Published Rock Hill Herald - 3 hours ago]
Health Care Equipment Stocks Technical Insight ... [Published PR Newswire: Financial Services - 3 hours ago]
Clinical Trial Results, Product Approval Letter... [Published Financial Services - 4 hours ago]
AbbVie Shares Up 2% As Profit, Sales Beat Estim... [Published FOXBusiness.com - 4 hours ago]
Mylan Beats, Raises Earnings Guidance; Abbott D... [Published Yahoo! Finance - 4 hours ago]
Potential Abbott Laboratories (ABT) Trade Has 2... [Published MarketIntelligenceCenter.com - 4 hours ago]
Mylan Reports Strong Third-Quarter Results, Rai... [Published Bidness Etc - 4 hours ago]
AbbVie Reports Third-Quarter 2014 Financial Res... [Published Nasdaq - 4 hours ago]
Boo! The 5 scariest stocks of 2014 [Published CNN Money - 4 hours ago]
Global Glaucoma Devices Market 2014-2018 [Published MarketResearch.com - 6 hours ago]
Sprague campaign funds top $50,000 [Published Findlay Courier - 7 hours ago]
Top 4 NYSE Stocks In The Medical Appliances & E... [Published Benzinga.com - 7 hours ago]
Abbott Laboratories : Director/PDMR Shareholding [Published Investegate - 9 hours ago]
Fonterra Says China Lifts Suspension on Whey Pr... [Published Bloomberg - 9 hours ago]
For Cadila Healthcare's Pankaj Patel, Patents A... [Published Forbes India - 10 hours ago]
Insider Selling: Abbott Laboratories CEO Sells ... [Published American Banking News - 13 hours ago]
Is Mylan's Lively Third Quarter the Start of So... [Published Motley Fool Discussion Boards - 14 hours ago]
Strata Decision Technology is Named Winner of 1... [Published Vision Monday - 14 hours ago]
Mylan's (MYL) CEO Heather Bresch on Q3 2014 Res... [Published Seeking Alpha - 15 hours ago]
Mylan Profit Soars As Revenue Tops Estimates - WSJ [Published DailyMe.Com - 15 hours ago]
WHO ready to benchmark 'Alagang Balon Dagupan' ... [Published Balita.org - 15 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Health Care Equipment Stocks Technical Insight ... [Published PR Newswire: Financial Services - 3 hours ago]
LONDON, October 31, 2014 /PRNewswire/ --Investor-Edge has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), ResMed Inc. (NYSE: RMD), and Covidien PLC (NYSE: COV). Free ...
Potential Abbott Laboratories (ABT) Trade Has 2... [Published MarketIntelligenceCenter.com - 4 hours ago]
For a hedged play on Abbott Laboratories (ABT) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a Jan. '15 $44.00 covered call for a net debit in the $42.47 area. That is also the break-even stock price for the covered call. This ...
Abbott to acquire VC-backed Topera for $250 mln [Published PE Hub Blog - 21 hours ago]
Abbott has agreed to buy Topera , which is backed by New Enterprise Associates , for $250 million. Based in Menlo Park, Calif., Topera is a medical device firm focused on developing technologies that improve the diagnosis and treatment of atrial ...
BioNews [10.30.14] [Published eClinical Trends - 23 hours ago]
Top News HeadlineCompanyType Abbott Laboratories Pays $250 Million For Menlo Park Startup Topera Abbott Laboratories & ToperaAcquisition Pfizer Wins FDA Accelerated Approval For Meningitis Vaccine PfzierFDA Approval Volcano Corporation ...
The Daily Startup: Semiconductor Investors See ... [Published WSJ.com: Venture Capital Dispatch - Oct 30 2014]
SiTime , a semiconductor company whose technology coordinates the timing of functions that take place on chips, has agreed to be acquired by MegaChips for $200 million in cash, Deborah Gage reports for VentureWire. SiTime had raised about $90 million ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
A Body Slam For WWE Stock [Published Wall Street Journal What's News - May 16 2014]
1

Press Releases

sort by: Date | Relevance
Clinical Trial Results, Product Approval Letter... [Published Financial Services - 4 hours ago]
Recognition, Product Enhancement, Marketing App... [Published Financial Services - Oct 22 2014]
InvestorsObserver releases comments on Google, ... [Published Financial Services - Oct 13 2014]
Market Activity, Acquisition Closure, App Launc... [Published Financial Services - Oct 02 2014]
Health Care Equipment Equities under the Scanne... [Published Financial Services - Sep 26 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.